U.S. Markets close in 4 hrs 29 mins

Karuna Therapeutics, Inc. (KRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
110.00+1.69 (+1.56%)
As of 11:31AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close108.31
Open108.56
Bid109.65 x 900
Ask110.27 x 900
Day's Range107.61 - 110.22
52 Week Range65.75 - 146.97
Volume28,609
Avg. Volume218,846
Market Cap2.964B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.90
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est159.31
  • Karuna Therapeutics to Present at Upcoming Investor Conferences
    Business Wire

    Karuna Therapeutics to Present at Upcoming Investor Conferences

    Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in the following upcoming virtual investor conferences:

  • Karuna Therapeutics Announces Pricing of Public Offering of Common Stock
    Business Wire

    Karuna Therapeutics Announces Pricing of Public Offering of Common Stock

    Karuna Therapeutics, Inc. (NASDAQ: KRTX) ("Karuna"), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the pricing of an underwritten public offering of 2,083,334 shares of its common stock at a public offering price of $120.00 per share. The gross proceeds to Karuna from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $250.0 million. In addition, Karuna has granted the underwriters a 30-day option to purchase up to an additional 312,500 shares of common stock. The offering is expected to close on or about March 4, 2021, subject to customary closing conditions. All the shares in the proposed offering are to be sold by Karuna.

  • Karuna Therapeutics Announces Proposed Public Offering of Common Stock
    Business Wire

    Karuna Therapeutics Announces Proposed Public Offering of Common Stock

    Karuna Therapeutics, Inc. (NASDAQ: KRTX) ("Karuna"), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that it has commenced an underwritten public offering of $200.0 million of its common stock. Karuna also intends to grant the underwriters a 30-day option to purchase an additional $30.0 million of its common stock offered in the public offering. All the shares in the proposed offering are to be sold by Karuna.